The Latest Headlines at American Banking and Market News
Energous (WATT) – Research Analysts’ Weekly Ratings Updates
Energous (NASDAQ: WATT) recently received a number of ratings updates from brokerages and research firms: 4/16/2024 – Energous is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/8/2024... More of this article »
Edgewise Therapeutics (NASDAQ:EWTX) Stock Rating Reaffirmed by Truist Financial
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Truist Financial in a note issued to investors on Wednesday, Benzinga reports. They currently... More of this article »
Johnson & Johnson (NYSE:JNJ) Price Target Cut to $175.00
Johnson & Johnson (NYSE:JNJ – Get Free Report) had its price objective decreased by equities research analysts at Royal Bank of Canada from $181.00 to $175.00 in a research note issued to investors on Wednesday, Benzinga... More of this article »
Wedbush Reiterates Outperform Rating for Neurocrine Biosciences (NASDAQ:NBIX)
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a report issued on Wednesday, Benzinga reports. They currently have a... More of this article »
Lovesac (NASDAQ:LOVE) Now Covered by Maxim Group
Maxim Group initiated coverage on shares of Lovesac (NASDAQ:LOVE – Get Free Report) in a report issued on Wednesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $36.00 price target on the stock.... More of this article »
Progyny (NASDAQ:PGNY) Rating Reiterated by Truist Financial
Progyny (NASDAQ:PGNY – Get Free Report)‘s stock had its “buy” rating reissued by Truist Financial in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $46.00 price target... More of this article »
Inter Parfums (NASDAQ:IPAR) Rating Reiterated by BWS Financial
Inter Parfums (NASDAQ:IPAR – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at BWS Financial in a research report issued to clients and investors on Wednesday, Benzinga reports.... More of this article »
Haleon (NYSE:HLN) Now Covered by HSBC
Equities researchers at HSBC initiated coverage on shares of Haleon (NYSE:HLN – Get Free Report) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage set a “buy” rating on... More of this article »
The PNC Financial Services Group (NYSE:PNC) Rating Reiterated by Keefe, Bruyette & Woods
The PNC Financial Services Group (NYSE:PNC – Get Free Report)‘s stock had its “underperform” rating reaffirmed by investment analysts at Keefe, Bruyette & Woods in a research report issued to clients and... More of this article »
Royal Caribbean Cruises (NYSE:RCL) Now Covered by Mizuho
Stock analysts at Mizuho started coverage on shares of Royal Caribbean Cruises (NYSE:RCL – Get Free Report) in a research note issued on Wednesday, MarketBeat.com reports. The firm set a “buy” rating and a $164.00... More of this article »
Truist Financial Reiterates “Buy” Rating for UnitedHealth Group (NYSE:UNH)
UnitedHealth Group (NYSE:UNH – Get Free Report)‘s stock had its “buy” rating reissued by Truist Financial in a research report issued to clients and investors on Wednesday, Benzinga reports. They currently have... More of this article »
FB Financial (NYSE:FBK) Stock Rating Reaffirmed by Keefe, Bruyette & Woods
FB Financial (NYSE:FBK – Get Free Report)‘s stock had its “market perform” rating restated by equities research analysts at Keefe, Bruyette & Woods in a research report issued on Wednesday, Benzinga reports.... More of this article »
Mirum Pharmaceuticals (NASDAQ:MIRM) Now Covered by Stifel Nicolaus
Analysts at Stifel Nicolaus began coverage on shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) in a report issued on Wednesday, MarketBeat reports. The brokerage set a “buy” rating and a $48.00 price... More of this article »